Patent ductus arteriosus in very low birthweight infants: Complications of pharmacological and surgical treatment

Journal of Perinatal Medicine

Volumn 29, Issue 4, 2001, Pages 327-334

  Koehne, P S ^a   Bein, G ^a   Alexi Meskhishvili, V ^a   Weng, Y ^a   Buhrer C ^a   Obladen, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Patent ductus arteriosus; Very low birthweight infants

Indexed keywords

INDOMETACIN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG WITHDRAWAL; HEMODYNAMIC MONITORING; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MORTALITY; NECROTIZING ENTEROCOLITIS; OXYGEN SATURATION; PATENT DUCTUS ARTERIOSUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

BIRTH WEIGHT; BLOOD LOSS, SURGICAL; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; LIGATION; SURGICAL WOUND INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034878701     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2001.047     Document Type: Article

References (31)

1. A randomized controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth
2. Frequency and mechanism of neonatal thrombocytopenia
3. Recommendations for the postnatal use of indomethacin: An analysis of four separate treatment strategies
4. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants
5. In-situ emergency paediatric surgery in the intensive care unit
6. Use of neonatal intensive care unit as a safe place for neonatal surgery
7. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP)
8. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin
9. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants
10. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate
11. Early closure of the patent ductus arteriosus in very low-birth-weight infants: A controlled trial
12. Operative closure of patent ductus arteriosus in the neonatal intensive care unit
13. Management of patent ductus arteriosus: A comparison of operative v pharmacologic treatment
14. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm
15. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus
16. Surgical ligation of patent ductus arteriosus in very low birth weight infants: Is it safe?
17. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus
18. Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight?
19. Is surgical closure of patent ductus arteriosus a safe procedure in premature infants?
20. Thoracic sequelae after surgical closure of the patent ductus arteriosus in premature infants
21. Surgical ligation of patent ductus arteriosus in a neonatal intensive care setting is safe and cost effective
22. Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in preterm infants with a birth weight below 1500 g
23. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants
24. The CRIB (clinical risk index for babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units
25. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g
26. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus
27. Surgical closure of patent ductus arteriosus in 268 preterm infants
28. Necrotizing enterocolitis: Treatment based on staging criteria
29. Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin
30. Indomethacin therapy in premature infants with patent ductus arteriosus - Determination of therapeutic plasma levels
31. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus